Literature DB >> 26883

Inhibition of prolactin secretion by histidyl-proline-diketopiperazine.

K Bauer, K J Gräf, A Faivre-Bauman, S Beier, A Tixier-Vidal, H Kleinkauf.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 26883     DOI： 10.1038/274174a0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  6 in total

1.  Serotonin (5-HT) stimulates thyrotropin-releasing hormone (TRH) gene transcription in rat embryonic cardiomyocytes.

Authors:  Z X Shi; W Xu; M K Selmanoff; J F Wilber
Journal:  Endocrine       Date:  1997-04       Impact factor: 3.633

2.  Kinetics and pattern of degradation of thyrotropin-releasing hormone (TRH) in human plasma.

Authors:  J Møss; H Bundgaard
Journal:  Pharm Res       Date:  1990-07       Impact factor: 4.200

Review 3.  Drug-induced changes in prolactin secretion. Clinical implications.

Authors:  K Hell; H Wernze
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Nov-Dec

Review 4.  Histidyl-proline diketopiperazine: its biological role as a regulatory peptide.

Authors:  A Peterkofsky; F Battaini; Y Koch; Y Takahara; P Dannies
Journal:  Mol Cell Biochem       Date:  1982-01-16       Impact factor: 3.396

5.  Conformation for a beta-cyclodextrin monosubstituted with a cyclic dipeptide.

Authors:  B Di Blasio; V Pavone; F Nastri; C Isernia; M Saviano; C Pedone; V Cucinotta; G Impellizzeri; E Rizzarelli; G Vecchio
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

6.  Inverse control of prolactin and growth hormone gene expression: effect of thyroliberin on transcription and RNA stabilization.

Authors:  J N Laverriere; A Morin; A Tixier-Vidal; A T Truong; D Gourdji; J A Martial
Journal:  EMBO J       Date:  1983       Impact factor: 11.598
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.